Search   Feed   Browse   Add
Feed items 1 - 6 of 6 for July 2008

MedPage Today Rheumatology

Physicians.....get the latest breaking news on Rheumatology. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals.

Frankincense Extract Said to Reduce Osteoarthritis Pain - July 29, 2008

DAVIS, Calif. -- For patients with knee osteoarthritis, an extract of the Indian frankincense plant gave significant pain relief and reduced levels of a marker of joint pathology, researchers here said.
http://www.medpagetoday.com/Rheumatology/Arthritis/tb/10321

Biologics and Combinations Top Arthritis Recommendations - July 24, 2008

ATLANTA -- Early, aggressive treatment of rheumatoid arthritis with biologic agents and potent drug combinations has moved front and center in the American College of Rheumatology practice guidelines.
http://www.medpagetoday.com/Rheumatology/Arthritis/tb/10252

Combo Drug Treatment Scores for Early Rheumatoid Arthritis - July 15, 2008

LEEDS, England -- Combining methotrexate and etanercept (Enbrel) for early moderate-to-severe rheumatoid arthritis improved remission and progression rates within a year, a randomized trial found.
http://www.medpagetoday.com/Rheumatology/Arthritis/tb/10131

Abatacept (Orencia) Improved Arthritis in Kids, but Study Design Criticized - July 14, 2008

GENOA, Italy -- Children with idiopathic arthritis unresponsive to other drugs improved on abatacept (Orencia) compared with those given a placebo, a randomized withdrawal trial found.
http://www.medpagetoday.com/Rheumatology/Arthritis/tb/10116

Outcomes Excellent for Joint Replacement in Older Adults - July 14, 2008

BOSTON -- Older patients who had hip or knee replacement for severe osteoarthritis took several weeks to recover but had excellent long-term outcomes, a prospective study found.
http://www.medpagetoday.com/PrimaryCare/Geriatrics/tb/10105

Multitargeted Immune Therapy Scores Well for Severe Lupus Nephritis - July 2, 2008

NANJING, China -- In patients with severe combined lupus nephritis, multitargeted immune therapy led to more than a six-fold increase in the rate of complete remissions compared with intravenous cyclophosphamide, investigators here reported.
http://www.medpagetoday.com/Rheumatology/Lupus/tb/9997
Available Archives
- June (9 items)
- July (6 items)
Sponsored Links
© 2008 FeedCapsule.com  |  Contact